Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 28, 2015; 21(8): 2413-2418
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2413
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2413
Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome
Fu-Liang He, Lei Wang, Hong-Wei Zhao, Zhen-Hua Fan, Meng-Fei Zhao, Shan Dai, Zhen-Dong Yue, Fu-Quan Liu, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
Author contributions: Liu FQ designed the research; He FL, Wang L, Zhao HW and Yue ZD performed the research; Zhao MF and Dai S contributed new reagents and analytical tools; Fan ZH analyzed the data; He FL wrote the paper.
Ethics approval: The study was reviewed and approved by the Beijing Shijitan Hospital Institutional Review Board.
Informed consent: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest: The authors have no potential conflict of interests.
Data sharing: Technical appendix, statistical code and dataset are available from the corresponding author at liufq_sjt@163.com.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Fu-Quan Liu, MD, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Haidian District, Beijing 100038, China. liufq_sjt@163.com
Telephone: +86-10-63926269 Fax: +86-10-63926325.
Received: October 17, 2014
Peer-review started: October 17, 2014
First decision: November 14, 2014
Revised: December 18, 2014
Accepted: January 8, 2015
Article in press: January 8, 2015
Published online: February 28, 2015
Processing time: 134 Days and 6.8 Hours
Peer-review started: October 17, 2014
First decision: November 14, 2014
Revised: December 18, 2014
Accepted: January 8, 2015
Article in press: January 8, 2015
Published online: February 28, 2015
Processing time: 134 Days and 6.8 Hours
Core Tip
Core tip: Jaundice with bilirubin > 51.3 μmol/L (3 mg/dL) is a contraindication for transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis or end-stage liver disease. However, 21 patients in our single center underwent TIPS due to severe jaundice secondary to acute Budd-Chiari syndrome (BCS) and good clinical outcomes were achieved. We present a single center clinical experience and discuss the feasibility and effectiveness of treating severe jaundice secondary to acute BCS with TIPS.